Literature DB >> 16507222

Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis.

Jay F Piccirillo1, Anna Vlahiotis.   

Abstract

At the time of diagnosis, many patients with head and neck cancer have other medical conditions, referred to as comorbidity. These other medical conditions may affect treatment and prognosis. Several valid instruments are available to capture the individual comorbid ailments and their prognostic impact. Inclusion of comorbidity information will assist in the analysis of treatment effectiveness, quality of care assessment, and outcomes studies based on observational studies.

Entities:  

Mesh：

Year:  2006        PMID： 16507222     DOI： 10.1007/s11912-006-0047-z

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  17 in total

1.  Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Authors:  Joan L Warren; Carrie N Klabunde; Deborah Schrag; Peter B Bach; Gerald F Riley
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

2.  Chemoradiation for metastatic SCCA: role of comorbidity.

Authors:  B Hathaway; J T Johnson; J F Piccirillo; C H Snyderman; R L Wagner; S Labriola; E N Myers
Journal:  Laryngoscope       Date:  2001-11       Impact factor: 3.325

3.  The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus.

Authors:  M H Kaplan; A R Feinstein
Journal:  J Chronic Dis       Date:  1974-09

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.

Authors:  Christine G Gourin; William J McAfee; Kimberly M Neyman; Jed W Howington; Robert H Podolsky; David J Terris
Journal:  Laryngoscope       Date:  2005-08       Impact factor: 3.325

6.  Elderly patients with head and neck cancer: the influence of comorbidity on choice of therapy, complication rate, and survival.

Authors:  Wynia Derks; Rob J de Leeuw; Gerrit Jan Hordijk
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2005-04       Impact factor: 2.064

7.  A comparison of three comorbidity indexes in a head and neck cancer population.

Authors:  Britt C Reid; Anthony J Alberg; Ann C Klassen; R Gary Rozier; Isabel Garcia; Deborah M Winn; Jonathan M Samet
Journal:  Oral Oncol       Date:  2002-02       Impact factor: 5.337

8.  Flaws in mortality data. The hazards of ignoring comorbid disease.

Authors:  S Greenfield; H U Aronow; R M Elashoff; D Watanabe
Journal:  JAMA       Date:  1988-10-21       Impact factor: 56.272

9.  Alcoholism: independent predictor of survival in patients with head and neck cancer.

Authors:  F W Deleyiannis; D B Thomas; T L Vaughan; S Davis
Journal:  J Natl Cancer Inst       Date:  1996-04-17       Impact factor: 13.506

10.  Prognostic importance of comorbidity in a hospital-based cancer registry.

Authors:  Jay F Piccirillo; Ryan M Tierney; Irene Costas; Lori Grove; Edward L Spitznagel
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272
View more
  13 in total

1.  Comorbidity is an independent predictor of health-related quality of life in a longitudinal cohort of head and neck cancer patients.

Authors:  Arild André Østhus; Anne K H Aarstad; Jan Olofsson; Hans J Aarstad
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-09       Impact factor: 2.503

2.  Predictors of pain among patients with head and neck cancer.

Authors:  Andrew G Shuman; Jeffrey E Terrell; Emily Light; Gregory T Wolf; Carol R Bradford; Douglas Chepeha; Yunyun Jiang; Scott McLean; Tamer A Ghanem; Sonia A Duffy
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-12-01

3.  Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom.

Authors:  Junko Takeshita; Shuwei Wang; Daniel B Shin; Nehal N Mehta; Stephen E Kimmel; David J Margolis; Andrea B Troxel; Joel M Gelfand
Journal:  JAMA Dermatol       Date:  2015-02       Impact factor: 10.282

4.  Treatment Outcomes of Sinonasal Malignancies Involving the Orbit.

Authors:  Chul Ho Shin; Ho Jun Lee; Yoo-Sam Chung; Ji Heui Kim
Journal:  J Neurol Surg B Skull Base       Date:  2021-05-29

Review 5.  Quality of life of oropharyngeal cancer patients treated with brachytherapy.

Authors:  David N Teguh; Peter C Levendag; Inger-Karine Kolkman-Deurloo; Peter van Rooij; Paul I M Schmitz
Journal:  Curr Oncol Rep       Date:  2009-03       Impact factor: 5.075

6.  Comorbidity, human papillomavirus infection and head and neck cancer survival in an ethnically diverse population.

Authors:  Ashish A Ankola; Richard V Smith; Robert D Burk; Michael B Prystowsky; Catherine Sarta; Nicolas F Schlecht
Journal:  Oral Oncol       Date:  2013-07-25       Impact factor: 5.337

7.  Free flap reconstruction for head and neck cancer can be safely performed in both young and elderly patients after careful patient selection.

Authors:  Thomas T A Peters; Sophie F Post; Boukje A C van Dijk; Jan L N Roodenburg; Bernard F A M van der Laan; Paul M N Werker; Gyorgy B Halmos
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-13       Impact factor: 2.503

Review 8.  Surgical salvage of recurrent cancer of the head and neck.

Authors:  Mark Zafereo
Journal:  Curr Oncol Rep       Date:  2014-05       Impact factor: 5.075

9.  Selection of Ideal Candidates for Surgical Salvage of Head and Neck Squamous Cell Carcinoma: Effect of the Charlson-Age Comorbidity Index and Oncologic Characteristics on 1-Year Survival and Hospital Course.

Authors:  JeeHong Kim; Seungwon Kim; William G Albergotti; Phillip A Choi; Daniel James Kaplan; Shira Abberbock; Jonas T Johnson; Neil Gildener-Leapman
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-12       Impact factor: 6.223

10.  Multimorbidity and blood pressure control in 37 651 hypertensive patients from Danish general practice.

Authors:  Maja S Paulsen; Morten Andersen; Janus L Thomsen; Henrik Schroll; Pia V Larsen; Jesper Lykkegaard; Ib A Jacobsen; Mogens L Larsen; Bo Christensen; Jens Sondergaard
Journal:  J Am Heart Assoc       Date:  2012-12-31       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.